1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 18 JANUARY 2016

Key Pharma News 18 JANUARY 2016

  • January 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Pay-For-Delay Challenges Are Changing The Patent Settlement Landscape
Industry Trend Analysis - Sanofi Seeking Innovative Differentiation To Grow
Industry Trend Analysis - Afrezza Agreement Termination An Opportunity Rather Than An Obstacle
Industry Brief - Takeda/Teva Business Venture Takes Shape
Industry Trend Analysis - Momenta Agreement Adds To Momentum Propelling Mylan Into Biosimilar Sphere
Industry Trend Analysis - IBD Research Set To Benefit From Synchronicity In 2016
Industry Trend Analysis - Collaboration Key To Arena And BI's Neuroscience Research
Industry Trend Analysis - Roche Building Capacity To Front Next Generation Epigenetic Drug Development
Industry Trend Analysis - Resolution Positions Stada To Capitalise On Serbian Sales Growth
Industry Trend Analysis - Lilly Stabilising After Patent Slump
Industry Trend Analysis - Takeda's Recovery Will Be Rooted In Development Partnerships
Industry Brief - Shire To Combine With Baxalta
Industry Trend Analysis - Risperdal Controversy Costs Continue To Rise
Industry Brief - Pfizer Acquires Treerly Health
Industry Trend Analysis - Laquinimod Viability In Doubt
Industry Brief - Gilead Submits Tenofovir Alafenamide NDA For HBV In US
Industry Brief - Mylan Launches Ledipasvir/Sofosbuvir In India
Industry Brief - AbbVie Initiates Six Global Phase III Studies Of Pan-Genotypic All-Oral HCV Regimen
Industry Trend Analysis - Heplisav-B Represents Potential To Upscale Success
Industry Trend Analysis - Gilead Diversification Risks Mitigated By Strong Core
Industry Trend Analysis - Precision Medicine Reinvigorating Pfizer

Table Of Contents

Key Pharma News 18 JANUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


Download Unlimited Documents from Trusted Public Sources

Emergency Contraception Market in the US

  • March 2017
    5 pages
  • Emergency Contr...  

  • United States  

View report >

Opioid Market in China

  • March 2017
    4 pages
  • Opioid  

  • China  

View report >

Hormone and Therapy Market in Pakistan and the US

  • March 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Therapy Market

2 days ago

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.